ASPH
protein-codingaspartate beta-hydroxylase
Gene summary
This gene is thought to play an important role in calcium homeostasis. The gene is expressed from two promoters and undergoes extensive alternative splicing. The encoded set of proteins share varying amounts of overlap near their N-termini but have substantial variations in their C-terminal domains resulting in distinct functional properties. The longest isoforms (a and f) include a C-terminal Aspartyl/Asparaginyl beta-hydroxylase domain that hydroxylates aspartic acid or asparagine residues in the epidermal growth factor (EGF)-like domains of some proteins, including protein C, coagulation factors VII, IX, and X, and the complement factors C1R and C1S. Other isoforms differ primarily in the C-terminal sequence and lack the hydroxylase domain, and some have been localized to the endoplasmic and sarcoplasmic reticulum. Some of these isoforms are found in complexes with calsequestrin, triadin, and the ryanodine receptor, and have been shown to regulate calcium release from the sarcoplasmic reticulum. Some isoforms have been implicated in metastasis. [provided by RefSeq, Sep 2009]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~214.1 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0011106
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0011106
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0018493
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0011106
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0011106
Submitter: Orphanet
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Ophthalmologic
Intervention: Ophthalmologic
Rationale: Early surgical removal of the lens has been reported as necessary in order to preserve visual function by preventing irreversible corneal and trabecular meshwork damage
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to ASPH variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_004318.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 1 | 32 | 2 | 36 | |
| missense | 2 | 95 | 11 | 2 | 110 | |
| nonsense | 6 | 5 | 11 | |||
| start loss | 0 | |||||
| frameshift | 4 | 6 | 2 | 1 | 13 | |
| splice donor/acceptor (+/-2bp) | 5 | 15 | 20 | |||
| Total | 10 | 19 | 113 | 44 | 4 | 190 |
Highest pathogenic variant AF is 0.00005142962
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_004309.2 | 25 | MANE Select | |
| Ensembl | ENSP00000368767.4 | 25 | MANE Select | |
| RefSeq | NP_001158222.1 | 25 | Standard | |
| RefSeq | NP_001158223.1 | 15 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- hypoxia-inducible factor in the cardivascular system
- Stimuli-sensing channels
- Ion channel transport
- Ion homeostasis
- Transport of small molecules
Biological Process
- muscle contraction
- pattern specification process
- negative regulation of cell population proliferation
- electron transport chain
- regulation of protein stability
Molecular Function
- peptide-aspartate beta-dioxygenase activity
- structural molecule activity
- calcium ion binding
- protein binding
- structural constituent of muscle
Cellular Component
- endoplasmic reticulum
- endoplasmic reticulum membrane
- plasma membrane
- integral component of membrane
- cortical endoplasmic reticulum
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000379454
- Coding exons
- 25
- Length
- 214040
- Individuals with no LoFs
- 125667
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 81
- Defined
- 125748
- p
- 0.000322
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.207 | 388 | 400 | 0.971 | 0.0000209 | 4988 |
| Missense (PolyPhen) | 114 | 144.19 | 0.79064 | 1694 | ||
| Synonymous | -0.595 | 156 | 147 | 1.06 | 0.00000825 | 1338 |
| Loss of Function | 2.59 | 31 | 51.0 | 0.608 | 0.00000251 | 614 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00038 | 0.00037 | rare |
| Latino/Admixed American | 0.00053 | 0.00052 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.000059 | 0.000054 | rare |
| Finnish | 0.00014 | 0.00014 | rare |
| European (Non-Finnish) | 0.00036 | 0.00036 | rare |
| South Asian | 0.00039 | 0.00036 | rare |
| Other | 0.00016 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Isoform 1: specifically hydroxylates an Asp or Asn residue in certain epidermal growth factor-like (EGF) domains of a number of proteins. {ECO:0000269|PubMed:11773073}.;
Recessive Scores
- pRec
- 0.181
Intolerance Scores
- LoFtool
- 0.988
- RVIS EVS
- -1.24
- RVIS percentile EVS
- 5.52
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.658
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |